We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
This guidance relates to Standard Essential Patents licensing.
Climate change is happening and is due to human activities; along with warming, many other changes are occurring such as melting polar ice, rising sea levels and more frequent floods, droughts and heatwaves.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Using an ecological momentary assessment to evaluate your digital health product.
Find out what reducing parental conflict is and about the work of the Reducing Parental Conflict Programme.
Whistleblowing - what it is, who to tell, what to expect and how to complain if you're treated unfairly
Guidance for manufacturers, importers and distributors.
Documents, certificate, letters, and notes available from the British embassy and consulates in the USA.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).